Kazia Therapeutics (KZIA) Inventory Average (2009 - 2010)
Kazia Therapeutics (KZIA) reported Inventory Average of $1.2 million for Q4 2010, up 38.01% on a YoY basis from $882069.4 in Q4 2009, and up 14.22% quarter-over-quarter from $1.1 million in Q2 2010.
Kazia Therapeutics (KZIA) Inventory Average (2009 - 2010) Analysis & Trends
Kazia Therapeutics has reported Inventory Average for 2 years, with the latest figure at $1.2 million in Q4 2010.
- For the quarter ending Q4 2010, Inventory Average rose 38.01% year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2010 stood at $1.2 million (up 38.01% YoY), and the FY2010 full-year result was $1.2 million, up 13.8% from the prior year.
- Inventory Average for Q4 2010 stood at $1.2 million, up from $1.1 million in the prior quarter.
- The five-year high for Inventory Average was $1.2 million in Q4 2010, with the low at $882069.4 in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Kazia Therapeutics | 1.70 Bn | 1.70 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 1.22 Mn |
| Jun 30, 2010 | 1.07 Mn |
| Dec 31, 2009 | 882,069.44 |
| Jun 30, 2009 | 898,156.42 |